4//SEC Filing
Currie Graeme Martin 4
Accession 0001213900-24-019216
CIK 0001841330other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 9:45 PM ET
Size
5.8 KB
Accession
0001213900-24-019216
Insider Transaction Report
Form 4
Currie Graeme Martin
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2024-03-01+5,938→ 5,938 totalExercise: $8.34Exp: 2034-02-28→ Common Stock (5,938 underlying)
Footnotes (1)
- [F1]The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The Option fully vested upon issuance and became exercisable on March 1, 2024.
Documents
Issuer
Pasithea Therapeutics Corp.
CIK 0001841330
Entity typeother
Related Parties
1- filerCIK 0001965006
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 9:45 PM ET
- Size
- 5.8 KB